Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer

ClinicalTrials.gov ID: NCT00083993

Public ClinicalTrials.gov record NCT00083993. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 7:37 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study of Oral CCI-779 Administered in Combination With Letrozole vs. Letrozole Alone as First Line Hormonal Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

In this clinical research study, postmenopausal subjects with metastatic breast cancer will be given either the combination of temsirolimus (CCI-779) and letrozole or a placebo and letrozole in first-line hormonal treatment. The primary endpoint of this study is to determine overall progression free survival. Individual subjects will participate in the active treatment phase of the study until disease progression or withdrawal of consent, provided that test article is being tolerated. All subjects will be asked to participate in the long-term follow-up phase of the study, which includes follow-up every 3 months until disease progression (for subjects who withdraw for reasons other than documented progressive disease) or until any new cancer treatment is received, and for survival. The estimated duration of study participation is 34 months.

Study identification

NCT ID
NCT00083993
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Enrollment
1,236 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2004 (Type not available)
Primary completion
Oct 2006 (Actual)
Completion
Oct 2006 (Actual)
Last update posted
Nov 8, 2011

2004 – 2006

United States locations

U.S. sites
112
U.S. states
38
U.S. cities
101
Facility City State ZIP Site status
Not listed Hoover Alabama 35216 —
Not listed Huntsville Alabama 35801 —
Not listed Tucson Arizona 85715 —
Not listed Jonesboro Arkansas 72401 —
Not listed Burbank California 91505 —
Not listed Campbell California 95008 —
Not listed Fountain Valley California 92708 —
Not listed Gilroy California 95020 —
Not listed Glendora California 91740 —
Not listed Modesto California 95355 —
Not listed Montebello California 90640 —
Not listed Pomona California 91767 —
Not listed Poway California 92064 —
Not listed Sacramento California 95816 —
Not listed San Diego California 92123 —
Not listed Santa Rosa California 95405 —
Not listed Soquel California 95073 —
Not listed Vista California 92083 —
Not listed Lakewood Colorado 80215 —
Not listed Norwalk Connecticut 06851 —
Not listed Washington D.C. District of Columbia 20010 —
Not listed Boca Raton Florida 33428 —
Not listed Fort Lauderdale Florida 33305 —
Not listed Hollywood Florida 33021 —
Not listed Jacksonville Florida 32209 —
Not listed Jacksonville Florida 32224 —
Not listed Lake Worth Florida 33461 —
Not listed Miami Shores Florida 33138 —
Not listed New Port Richey Florida 34652 —
Not listed Plantation Florida 33324 —
Not listed Sarasota Florida 34239 —
Not listed Zephyrhills Florida 33542 —
Not listed Atlanta Georgia 30309-1710 —
Not listed Columbus Georgia 31902 —
Not listed Roswell Georgia 30076 —
Not listed Thomasville Georgia 31792 —
Not listed Coeur d'Alene Idaho 83814 —
Not listed Centralia Illinois 62801 —
Not listed Skokie Illinois 60076 —
Not listed Skokie Illinois 60077 —
Not listed Springfield Illinois 62702 —
Not listed Urbana Illinois 61801 —
Not listed Munster Indiana 46321 —
Not listed South Bend Indiana 46601 —
Not listed Lexington Kentucky 40504 —
Not listed Baltimore Maryland 21201 —
Not listed Baltimore Maryland 21231 —
Not listed Baltimore Maryland 21237 —
Not listed Bethesda Maryland 20817 —
Not listed Frederick Maryland 21701 —
Not listed Towson Maryland 21204 —
Not listed Boston Massachusetts 02118 —
Not listed Boston Massachusetts 02135 —
Not listed Ann Arbor Michigan 48109 —
Not listed Detroit Michigan 48202 —
Not listed Flint Michigan 48503 —
Not listed Grand Rapids Michigan 49503 —
Not listed Grand Rapids Michigan 49546 —
Not listed Minneapolis Minnesota 55455 —
Not listed Hattiesburg Mississippi 39401 —
Not listed Rolla Missouri 65401 —
Not listed Great Falls Montana 59406 —
Not listed Omaha Nebraska 68198 —
Not listed Carson City Nevada 89703 —
Not listed Lebanon New Hampshire 03756 —
Not listed Belleville New Jersey 07109 —
Not listed Somerset New Jersey 08873 —
Not listed Albuquerque New Mexico 87109 —
Not listed Binghamton New York 13905 —
Not listed East Syracuse New York 13057 —
Not listed New York New York 10032 —
Not listed Nyack New York 10960 —
Not listed Staten Island New York 10305 —
Not listed Charlotte North Carolina 28203 —
Not listed Gastonia North Carolina 28054 —
Not listed Wilmington North Carolina 28401 —
Not listed Winston-Salem North Carolina 27103 —
Not listed Bismarck North Dakota 58504 —
Not listed Canton Ohio 44710 —
Not listed Canton Ohio 44718 —
Not listed Cincinnati Ohio 45219 —
Not listed Cincinnati Ohio 45238 —
Not listed Cleveland Ohio 44106-5055 —
Not listed Cleveland Ohio 44195 —
Not listed Columbus Ohio 43215 —
Not listed Columbus Ohio 43235 —
Not listed Mayfield Heights Ohio 44124 —
Not listed Corvallis Oregon 97330 —
Not listed Portland Oregon 97213 —
Not listed Harrisburg Pennsylvania 17110 —
Not listed Hershey Pennsylvania 17033 —
Not listed Langhorne Pennsylvania 19047 —
Not listed Philadelphia Pennsylvania 19106 —
Not listed Pittsburgh Pennsylvania 15213 —
Not listed Charleston South Carolina 29425 —
Not listed Columbia South Carolina 29169 —
Not listed Chattanooga Tennessee 37404 —
Not listed Nashville Tennessee 37203 —
Not listed Nashville Tennessee 37205 —
Not listed Arlington Texas 76012 —
Not listed Corpus Christi Texas 78412 —
Not listed Dallas Texas 75230 —
Not listed Fort Worth Texas 76104 —
Not listed Irving Texas 75038 —
Not listed Tyler Texas 75701 —
Not listed Logan Utah 84341 —
Not listed Ogden Utah 84403 —
Not listed Arlington Virginia 22205-3637 —
Not listed Richmond Virginia 23294 —
Not listed Woodbridge Virginia 22191 —
Not listed Seattle Washington 98101 —
Not listed Morgantown West Virginia 26505 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00083993, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 8, 2011 · Synced Nov 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00083993 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →